Annual Operating Expenses
$30.40 M
-$57.45 M-65.39%
31 December 2022
Summary:
Catalyst Biosciences annual total operating expenses is currently $30.40 million, with the most recent change of -$57.45 million (-65.39%) on 31 December 2022. During the last 3 years, it has fallen by -$57.45 million (-65.39%).CBIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.62 M
-$920.00 K-36.18%
30 September 2023
Summary:
Catalyst Biosciences quarterly total operating expenses is currently $1.62 million, with the most recent change of -$920.00 thousand (-36.18%) on 30 September 2023.CBIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -65.4% | -92.0% |
| 5 y5 years | -46.9% | -88.4% |
CBIO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -71.7% | -94.4% |
Catalyst Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $1.62 M(-36.2%) |
| June 2023 | - | $2.54 M(-44.2%) |
| Mar 2023 | - | $4.56 M(-5.5%) |
| Dec 2022 | $30.40 M(-65.4%) | $4.83 M(-6.6%) |
| Sept 2022 | - | $5.17 M(-9.6%) |
| June 2022 | - | $5.71 M(-61.1%) |
| Mar 2022 | - | $14.70 M(-27.6%) |
| Dec 2021 | $87.85 M(+27.0%) | $20.30 M(-19.5%) |
| Sept 2021 | - | $25.22 M(+26.7%) |
| June 2021 | - | $19.91 M(-11.2%) |
| Mar 2021 | - | $22.43 M(+19.0%) |
| Dec 2020 | $69.16 M(+20.7%) | $18.84 M(+17.2%) |
| Sept 2020 | - | $16.08 M(-6.9%) |
| June 2020 | - | $17.28 M(+1.9%) |
| Mar 2020 | - | $16.95 M(+21.2%) |
| Dec 2019 | $57.28 M(+69.3%) | $13.99 M(+6.0%) |
| Sept 2019 | - | $13.20 M(-8.2%) |
| June 2019 | - | $14.38 M(-8.5%) |
| Mar 2019 | - | $15.71 M(+34.5%) |
| Dec 2018 | $33.83 M(+48.1%) | $11.68 M(+40.0%) |
| Sept 2018 | - | $8.35 M(+17.3%) |
| June 2018 | - | $7.11 M(+6.4%) |
| Mar 2018 | - | $6.68 M(+8.8%) |
| Dec 2017 | $22.84 M(+9.7%) | $6.15 M(-0.8%) |
| Sept 2017 | - | $6.20 M(+2.3%) |
| June 2017 | - | $6.05 M(+36.3%) |
| Mar 2017 | - | $4.44 M(-16.0%) |
| Dec 2016 | $20.82 M(+33.9%) | $5.29 M(-9.1%) |
| Sept 2016 | - | $5.82 M(+15.9%) |
| June 2016 | - | $5.02 M(+7.3%) |
| Mar 2016 | - | $4.68 M(-2.3%) |
| Dec 2015 | $15.55 M(-47.6%) | $4.79 M(+20.0%) |
| Sept 2015 | - | $3.99 M(+17.9%) |
| June 2015 | - | $3.39 M(-40.8%) |
| Mar 2015 | - | $5.73 M(+26.1%) |
| Dec 2014 | $29.67 M(-41.6%) | $4.54 M(-9.4%) |
| Sept 2014 | - | $5.01 M(-39.4%) |
| June 2014 | - | $8.28 M(-30.1%) |
| Mar 2014 | - | $11.84 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $50.84 M(-18.4%) | $13.40 M(+1.9%) |
| Sept 2013 | - | $13.15 M(+5.3%) |
| June 2013 | - | $12.49 M(+5.7%) |
| Mar 2013 | - | $11.81 M(-23.5%) |
| Dec 2012 | $62.28 M(-42.0%) | $15.44 M(+74.2%) |
| Sept 2012 | - | $8.87 M(-48.1%) |
| June 2012 | - | $17.10 M(-18.1%) |
| Mar 2012 | - | $20.87 M(-28.3%) |
| Dec 2011 | $107.38 M(+47.9%) | $29.09 M(+2.8%) |
| Sept 2011 | - | $28.29 M(+21.3%) |
| June 2011 | - | $23.31 M(-12.7%) |
| Mar 2011 | - | $26.69 M(+7.4%) |
| Dec 2010 | $72.60 M(+50.2%) | $24.85 M(+28.2%) |
| Sept 2010 | - | $19.38 M(+21.6%) |
| June 2010 | - | $15.94 M(+28.2%) |
| Mar 2010 | - | $12.43 M(-11.5%) |
| Dec 2009 | $48.35 M(+1.8%) | $14.05 M(+28.9%) |
| Sept 2009 | - | $10.90 M(-12.3%) |
| June 2009 | - | $12.43 M(+13.3%) |
| Mar 2009 | - | $10.96 M(-10.0%) |
| Dec 2008 | $47.48 M(+11.4%) | $12.18 M(+0.6%) |
| Sept 2008 | - | $12.11 M(-2.4%) |
| June 2008 | - | $12.41 M(+15.2%) |
| Mar 2008 | - | $10.77 M(-10.5%) |
| Dec 2007 | $42.63 M(+55.1%) | $12.04 M(+6.0%) |
| Sept 2007 | - | $11.36 M(-3.0%) |
| June 2007 | - | $11.71 M(+55.5%) |
| Mar 2007 | - | $7.53 M(-17.4%) |
| Dec 2006 | $27.48 M(-10.3%) | $9.11 M(+39.8%) |
| Sept 2006 | - | $6.52 M(+10.0%) |
| June 2006 | - | $5.93 M(-0.0%) |
| Mar 2006 | - | $5.93 M(-12.5%) |
| Dec 2005 | $30.64 M(+9.7%) | $6.78 M(-8.2%) |
| Sept 2005 | - | $7.38 M(-13.5%) |
| June 2005 | - | $8.54 M(+7.6%) |
| Mar 2005 | - | $7.94 M |
| Dec 2004 | $27.93 M(+28.3%) | - |
| Dec 2003 | $21.78 M(-5.5%) | - |
| Dec 2002 | $23.05 M(+120.4%) | - |
| Dec 2001 | $10.45 M | - |
FAQ
- What is Catalyst Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Catalyst Biosciences?
What is Catalyst Biosciences annual total operating expenses?
The current annual operating expenses of CBIO is $30.40 M
What is the all time high annual operating expenses for Catalyst Biosciences?
Catalyst Biosciences all-time high annual total operating expenses is $107.38 M
What is Catalyst Biosciences quarterly total operating expenses?
The current quarterly operating expenses of CBIO is $1.62 M
What is the all time high quarterly operating expenses for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly total operating expenses is $29.09 M